Article Text
Commentary
The multiple effects of tumour necrosis factor inhibitors on immune cells: new insights on inhibition of activation and cycling
Statistics from Altmetric.com
Footnotes
Linked article 301267.
Competing interests MA has received honoraria for consultancies from Abbott and has participated in continuing medical education events supported by unrestricted educational grants from Abbott, Centocor and Schering Corporation, a subsidiary of Merck & Co.
Provenance and peer review Commissioned; externally peer reviewed.